NCT07051928View on ClinicalTrials.gov

Study of Atezolizumab in Advanced Non-oncogene-addicted NSCLC With PD-L1 ≥50%, Including Longitudinal c-FLIP Assessment in Monocytic MDSCs.

Not yet recruitingOBSERVATIONAL
Enrollment

107

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2029

Conditions
Non Small Cell Lung Cancer
Interventions
DIAGNOSTIC_TEST

c-FLIP expression on MDSC

Longitudinal c-FLIP expression on circulating MDSC

Trial Locations (1)

00168

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER